medigraphic.com

2015, Number 1

<< Back Next >>

Revista Cubana de Angiología y Cirugía Vascular 2015; 16 (1)

Behaviour of the uric acid in the general casuistic and in patients with peripheral vascular disease

Álvarez PM, Triana MME

Language: Spanish
References: 17
Page: 37-43
PDF size: 96.56 Kb.


ABSTRACT

Objective: to determine the behaviour of the uric acid in a general casuistic and in the patients with vascular periphery disease and calculating the prevalence of hyperuricaemia.
Methods: a descriptive study in 464 patients assisted at aboratory of Biochemistry of the Institute of Angiology and Vascular Surgery during the month of may of 2013 and in the 85 patients with vascular periphery disease was analyzed. Uric acid quantified in alls with a commercial game of enzymatic reagent. The hyper-uricaemia determined itself when taking the following values into account: 415.4 µmol/ L for man and 339.0 µmol/L for woman. Was calculated the total prevalence of hyperuricaemia and tight-fitting according to sex.
Results: the concentration of uric acid in the sample was of 320.3 µmol/L (95 % CI: 310; 330,6) With difference between man and woman (354.1 vs. 29,3 µmol/L, p= 3,74 x 10-9). The patients with diabetic macroangiopathy had high concentration of uric acid (339.5 µmol/L) within significant difference with general casuistic. The prevalence of hyper-uricaemia was of the 27.6 %; of her the 24.8 % for the masculine sex and the 30.0 % for the feminine.
Conclusion: it is done called the reflection on this parameter, what has high prevalence, which must not be indicated like routine; since it can be a biomarker of vascular periphery disease as it is for the arterial hypertension, renal function and gout.


REFERENCES

  1. Alvarez-Lario B, Macarrón-Vicent J. Is there anything good in uric acid?. [review]. QJM. 2011;104:1015-24. doi: 1093/qjmd/hcr159.

  2. García PJ, Mateos FA. Clinical and biochemical aspects of uric acid overproduction. Pharm World Sci. 1994;16:40-54.

  3. Jacob G, Struthers AD. Role of urate, xanthine oxidase and the effects of Allopurinol in vascular oxidative stress. (Review). Vasc Health Risk Management. 2009;5:265-72.

  4. Nemec P. Current opinions on gout, its diagnosis and treatment. Vnitr Lek. 2012;58(12):928-37.

  5. Feig DI. Uric acid: a novel mediator and marker of risk in chronic kidney disease? Curr Opin Nephrol Hypertens. 2009;18:526-30.

  6. Liu Y, Tan N, Chen J, Zhou Y, Chen L, Chen S, Chen Z, Li L. The relationship between hyperuricemia and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with relatively normal serum creatinine. Clinics (Sao Paulo). 2013;68(1):19-25.

  7. Mazzali M, Kanbay M, Segal MS, Shafiu M, Jalal D, Feig D, et al. Uric acid and hypertension: cause or effect? Curr Rheumatol Rep. 2010;12:108-17.

  8. Bhole V, Choi JW, Kim SW, de Vera M, Choi H. Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med. 2010;123:957-61.

  9. Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S. Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology. 2009;114:300-5.

  10. López Argüelles J, Rojas Fuentes J, Verdecia Fraga R. Los niveles del acido úrico y su relación con la discapacidad en la fase aguda de la enfermedad cerebrovascular. Medisur. 2010 [citada 20 Dic 2013];8(1):3-7. Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/854

  11. Giuseppe L, Martina M, Massimo F, Emmanuel J, Favaloro, Giovanni Targher. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta. 2008;392:1-7.

  12. Álvarez Prats M, Triana Mantilla ME. El ácido úrico y su capacidad de ser o no un factor de riesgo de enfermedad vascular. Rev Cubana Angiol Cir Vasc. 2013 [citada 3 Ene 2014];14(2). Disponible en: http://www.bvs.sld.cu/revistas/ang/vol14_2_13/ang05213.htm

  13. Martinon F. Update on biology: uric acid and the activation of immune and inflammatory cells. Curr Rheumatol Rep. 2010;12:135-41.

  14. Ghaemi-Oskouie F, Shi Y. The role of uric acid as an endogenous danger signal in immunity and inflammation. Clin Rheumatol Rep. 2011;13:160-6.

  15. Wlascher M, Scharffetter Kochnek K. Oxidative stress in chronic venous leg ulcers. Wounds Repair Regen. 2005;13:452-61.

  16. Fernández ML, Upton Z, Edwards H, Finlayson K, Shooter GK. Elevated uric acid correlates with wounds severity. Int Wound. 2012;9 (2):139-49.

  17. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population. The National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136-41.




2020     |     www.medigraphic.com